Conditions Treated

Orthopedic and soft tissue conditions that affect the joints, tendons, ligaments, muscles, cartilage, and spine.

Knee: Restoring Joint Function

Osteoarthritis and Cartilage Degeneration
Regenerative biologics are commonly utilized in the treatment of early to moderate osteoarthritis, where progressive cartilage breakdown leads to pain, stiffness, and reduced joint mobility. By improving the joint environment and supporting cartilage health, these therapies aim to reduce symptoms and enhance overall function.

Meniscus Tears and Structural Stability
Meniscus injuries, particularly degenerative or partial tears, may benefit from biologic support that promotes tissue healing and improved joint stability. Targeted injections can help optimize the healing environment within the knee and support structural integrity.

Tendon and Ligament Injuries
In conditions such as patellar tendinopathy (jumper’s knee) and partial ligament injuries including MCL and ACL tears, regenerative biologics support collagen remodeling and tissue repair. By addressing chronic inflammation and micro-tearing, these therapies may strengthen injured fibers without the need for surgical reconstruction.

Chondromalacia Patella and Joint Irritation
Chondromalacia patella, characterized by softening and irritation of cartilage beneath the kneecap, can be addressed by reducing inflammation and supporting cartilage health. Image-guided biologic injections allow for precise delivery to affected tissues.

Shoulder: Strengthening Stability

Targeting the Root Causes of Shoulder Pain
Clinical strength Autologous Biologics are increasingly utilized in the treatment of common shoulder conditions that cause pain, weakness, and restricted motion. Partial-thickness rotator cuff tears, one of the most frequent sources of shoulder dysfunction, may benefit from clinical strength Autologous Biologic therapies that support tendon healing and structural integrity. By enhancing the local healing environment, these treatments aim to reduce pain while improving strength and range of motion.

Addressing Inflammation and Degenerative Changes
Biceps tendinitis and AC joint arthritis are also effectively addressed through targeted biologic injections. In these conditions, chronic inflammation and tissue degeneration contribute to persistent discomfort and mechanical irritation. Clinical strength Autologous Biologics helps modulate inflammation and stimulate collagen regeneration within tendons and surrounding soft tissues, promoting improved function and symptom relief.

Restoring Mobility and Structural Integrity
Frozen shoulder (adhesive capsulitis) and labral injuries involve stiffness, capsular thickening, or cartilage-related instability. Image-guided biologic injections can be delivered directly into the joint capsule or around damaged soft tissues to help reduce inflammation and support tissue recovery. Clinical strength Autologous Biologics, with its concentrated reparative cell population, may assist in repairing micro-tears and enhancing tendon and labral integrity.

Hip: Improving Mobility

Supporting Labral Integrity and Joint Stability
Clinical strength Autologous Biologics are increasingly used to address hip labral tears that contribute to pain, clicking, and mechanical instability. Precisely guided injections help improve the joint environment by reducing inflammation and supporting tissue recovery. This approach aims to enhance stability, decrease discomfort, and promote smoother hip motion.

Reducing Lateral Hip Pain and Tendon Dysfunction
Greater trochanteric pain syndrome and gluteal tendinopathy are common causes of persistent lateral hip pain, often related to chronic tendon overload and irritation of surrounding bursae. A clinical strength dose of Autologous Biologics may be used to modulate inflammation and support collagen repair within compromised tendons, improving strength and load tolerance over time.

Addressing Early Degenerative Joint Changes
In early-stage hip arthritis, biologic therapies can help manage joint inflammation and cartilage stress before advanced degeneration develops. Clinical doses of Autologous Biologics, containing a concentrated population of reparative cells, may be delivered under image guidance to support joint health and functional preservation.

Improving Flexibility and Restoring Motion
Iliopsoas tendinitis, a source of deep groin pain and restricted hip flexion, may benefit from targeted biologic placement around the inflamed tendon. Because the hip is a deep and complex joint, ultrasound or fluoroscopic guidance ensures accurate delivery. Together, these regenerative strategies aim to reduce inflammation, restore strength and flexibility, and improve range of motion.

Foot & Ankle: Get Back on Your Feet

Restoring Strength in the Achilles Tendon
Clinical strength autologous biologics are frequently used to treat Achilles tendinopathy, a condition characterized by chronic tendon degeneration and persistent heel pain. Targeted platelet-rich plasma (PRP) injections with clinical does of platelet content, may help modulate inflammation and stimulate collagen remodeling within damaged tendon fibers. This approach supports improved tendon structure, strength, and return to weight-bearing activity.

Relieving Heel Pain from Plantar Fasciitis
Plantar fasciitis, one of the most common causes of heel pain, often results from repetitive strain and micro-tearing of the plantar fascia. Precisely guided biologic injections can help reduce inflammation and promote tissue repair at the origin of the fascia. By enhancing the local healing response, patients may experience reduced morning pain and improved walking tolerance.

Repairing Peroneal and Posterior Tibial Tendon Injuries
Peroneal tendon injuries and posterior tibial tendon dysfunction can lead to ankle instability, arch collapse, and progressive pain. Clinical doses of Autologous Biologics  may be delivered directly to injured tendons to support fiber repair and structural reinforcement. These therapies aim to restore dynamic support of the ankle and improve functional alignment.

Stabilizing Ankle Ligaments and Preventing Chronic Instability
Ankle ligament sprains, particularly when recurrent, can progress to chronic instability if not properly healed. Biologic injections target injured ligament fibers to support tissue regeneration and strengthen the ligament complex. By accelerating healing from sprains and strains, regenerative therapies may reduce long-term instability and help patients return confidently to sport and daily activity without surgical intervention.

Spine: Precision for Restoration

Addressing Degenerative Disc Disease and Discogenic Pain
Clinical dose Autologous Biologics are increasingly utilized in the management of degenerative disc disease (DDD), annular tears, and discogenic pain. These conditions often involve disc dehydration, structural weakening, and inflammatory signaling that contribute to persistent back or neck pain. Precisely formulated biologic injections, delivered under fluoroscopic guidance, may support disc environment optimization, reduce inflammatory mediators, and promote cellular repair within affected spinal tissues.

Managing Facet Joint Arthritis and Mechanical Back Pain
Facet joint arthritis is a common source of axial spine pain caused by inflammation and degeneration of the small stabilizing joints in the posterior spine. Targeted biologic injections can help modulate inflammation within these joints while supporting structural integrity and improved motion. Customized formulations may reduce pain signaling and enhance local tissue recovery without surgical intervention.

Stabilizing Sacroiliac Joint Dysfunction
Sacroiliac (SI) joint dysfunction can produce lower back, pelvic, or radiating pain due to ligamentous laxity or joint inflammation. Image-guided delivery of clinical doses of Autologous Biologics may assist in strengthening supporting ligaments and reducing inflammation within the joint complex. This approach aims to improve joint stability, decrease nerve irritation, and restore functional biomechanics.

Precision-Guided Biologic Formulations for Spinal Care
Because spinal structures are anatomically complex and sensitive, biologic therapies are carefully customized for specific tissue targets and delivered under fluoroscopic guidance. Autologous biologic formulations can be selected based on the clinical indication to help reduce inflammatory pain signals and initiate reparative cellular responses. Together, these precision-driven strategies are designed to reduce pain and restore functional capacity while helping patients avoid more invasive surgical procedures.

Elbow: Healing From the Source

Targeting Lateral Epicondylitis (Tennis Elbow)
Clinical dose autologous biologics are commonly used to treat lateral epicondylitis, a condition caused by repetitive strain and micro-tearing of the extensor tendons. Targeted platelet-rich plasma (PRP) injections with therapeutic doses of platelets are delivered directly into the degenerative tendon tissue to stimulate collagen production and support structural repair. This approach aims to reduce pain, improve grip strength, and restore functional use of the arm.

Addressing Medial Epicondylitis (Golfer’s Elbow)
Medial epicondylitis involves inflammation and tendon degeneration along the inner elbow, often due to repetitive flexion and forearm strain. Precisely guided biologic injections help modulate inflammation while promoting tissue regeneration within the affected tendon fibers. Patients often experience improved strength, reduced discomfort, and enhanced performance in daily and athletic activities.

Supporting UCL Sprains in Throwing Athletes
Ulnar collateral ligament (UCL) sprains, particularly common in overhead and throwing athletes, can compromise elbow stability and performance. Autologous biologics may be delivered under image guidance to support ligament healing and strengthen compromised fibers. These therapies are designed to promote recovery while potentially reducing the need for surgical reconstruction.

Reversing Tendinosis and Chronic Inflammation
Chronic elbow pain frequently stems from tendinosis, degenerative tendon changes without adequate healing. Autologous biologic injections target the underlying tissue breakdown by stimulating a regenerative response at the source of injury. Outcomes often include accelerated recovery, decreased inflammation, and restoration of strength and endurance, particularly important for active individuals and competitive athletes.